Peptides DB
Research-centric peptide and protocol reference hub
Study 21 of 24ARA 290 literatureCell cycle (Georgetown, Tex.) · Observational · Preclinical2026

Identification of PGF+ endothelial cells associated with plaque instability in carotid atherosclerosis by scRNA-seq and RNA-seq analysis.

This study identifies pro-inflammatory endothelial cell subsets associated with plaque instability in atherosclerosis, highlighting the complexity of endothelial cell roles in vascular health.

Read at Cell cycle (Georgetown, Tex.)Add to compare

Where it sits

this study against the rest of the ara 290 corpus
2
Preclinical
19
Observational · this one
1
Open-label
0
Randomised
2
Reviews

Summary and findings

This study analyzed endothelial cell heterogeneity in carotid atherosclerosis using single-cell RNA sequencing and bulk RNA sequencing. It identified three endothelial cell subsets significantly enriched in unstable plaques, associated with pro-inflammatory cytokine upregulation. Findings were validated in an ApoE-/- mouse model showing increased placental growth factor expression.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.Preclinical2026

Abstract

The authors’ words, as Cell cycle (Georgetown, Tex.) supplied them

Vascular endothelial dysfunction plays a critical role in the development of atherosclerosis; however, the mechanisms by which endothelial cells contribute to plaque instability remain incompletely understood. In this study, we performed an integrated analysis of single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq data to characterize endothelial cell heterogeneity associated with carotid plaque instability. Clustering analysis, gene set variation analysis (GSVA), differential gene expression analysis, and KEGG pathway enrichment were conducted to identify key endothelial cell subsets and their functional characteristics. We identified three endothelial cell subsets (subsets 9, 10, and 11) that were significantly enriched in unstable plaques and exhibited upregulation of multiple pro-inflammatory cytokines. Pathway analysis revealed that these subsets were associated with activation of the PI3K - Akt signaling pathway and other inflammation-related pathways. Furthermore, findings were validated in an apolipoprotein E-deficient (ApoE-/-) mouse model, where increased expression of placental growth factor (PGF) and a higher proportion of PGF-positive endothelial cells were observed in atherosclerotic lesions. In conclusion, this study reveals the heterogeneity of endothelial cells in atherosclerotic plaques and identifies pro-inflammatory endothelial subsets potentially associated with plaque instability, providing new insights into the pathogenesis of atherosclerosis.<b>Trial registration</b>: This study was approved by the Experimental Animal Ethics Committee of Guizhou University of Chinese Medicine (approval number: 2,024,010).

Background

This paper addresses the role of vascular endothelial dysfunction in atherosclerosis, particularly how endothelial cells contribute to plaque instability. Prior research has indicated that endothelial cell heterogeneity may influence atherosclerotic progression, but specific mechanisms remain unclear. Understanding these mechanisms could provide insights into potential therapeutic targets for atherosclerosis management.

Methods

The study utilized single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing to analyze endothelial cell populations associated with carotid plaque instability. The population studied included endothelial cells from atherosclerotic plaques, with a focus on identifying key subsets. The analysis involved clustering, gene set variation analysis (GSVA), differential gene expression analysis, and KEGG pathway enrichment.

Results

The study identified three endothelial cell subsets (subsets 9, 10, and 11) that were significantly enriched in unstable plaques. These subsets exhibited upregulation of multiple pro-inflammatory cytokines and were associated with the activation of the PI3K - Akt signaling pathway. In the ApoE-/- mouse model, increased expression of placental growth factor (PGF) and a higher proportion of PGF-positive endothelial cells were observed in atherosclerotic lesions.

Interpretation

The findings contribute to the understanding of endothelial cell heterogeneity in atherosclerosis and suggest a link between pro-inflammatory endothelial subsets and plaque instability. However, the effect sizes and clinical significance of these findings remain unclear, particularly given the reliance on animal models. The study's conclusions may be limited by the lack of direct human evidence and the potential for confounding factors in the mouse model.

Key findings

  • Three endothelial cell subsets (subsets 9, 10, and 11) significantly enriched in unstable plaques.
  • Upregulation of multiple pro-inflammatory cytokines in identified endothelial subsets.
  • Activation of the PI3K - Akt signaling pathway in these subsets.
  • Increased expression of placental growth factor (PGF) in atherosclerotic lesions in ApoE-/- mice.
  • Higher proportion of PGF-positive endothelial cells observed in atherosclerotic lesions.

Limitations

  • Findings based on mouse models, not directly applicable to humans.
  • Correlational data does not establish causation.
  • Single-site study may limit generalizability.
  • Short follow-up period in animal model.

Elsewhere in the ARA 290 corpus

DWorldwide diversity of hepatitis A and E viruses in urban wastewaterbiorxiv-preprint · 2026 · 70% of cities detected Rocahepevirus ratti (rat HEV) genotype C1.reviewBDesigning for healthy ageing: Lessons learned from engaging pre-frail older adults in the development of digital self-monitoring health technologiesbiorxiv-preprint · 2026 · Not reported in abstract.HumanBHigh-latitude occurrence of Phoebetria palpebrata in the Weddell Sea: new distribution limits and ecological implicationsbiorxiv-preprint · 2026 · Not reported in abstract.HumanCBGC1201: A potent allosteric SHP2 inhibitor with broad antitumor activity in lung, pancreatic, and esophageal cancer xenografts.Pharmaceutical science advances · 2026 · IC50 of 2.47 nM for SHP2-WT phosphatase inhibition.AnimalBInvasive mosquitoes in the non-endemic German region of Saarland: What does the public know and how does it respond?One health (Amsterdam, Netherlands) · 2026 · n=623 · 58.6% of respondents met the inclusion criteria, n=1064.HumanBA Pattern of Relatively Conserved Fluency Indicates Preclinical Minor Cognitive Declinebiorxiv-preprint · 2026 · 79.5% accuracy in identifying minor cognitive decline, 95% CI [73.2%, 84.9%]Human